TNDM Tandem Diabetes Care, Inc.

Price (delayed)

$107.29

Market cap

$6.53B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.7

Enterprise value

$6.53B

Sector: Healthcare
Industry: Medical Devices
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.

Highlights

Tandem Diabetes Care's quick ratio has soared by 93% YoY and by 92% from the previous quarter
The company's equity has surged by 84% YoY and by 29% QoQ
The net income has plunged by 154% from the previous quarter but it has increased by 23% YoY
Tandem Diabetes Care's EPS has plunged by 150% from the previous quarter but it has increased by 11% YoY

Key stats

What are the main financial stats of TNDM
Market
Shares outstanding
60.91M
Market cap
$6.53B
Enterprise value
$6.53B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
24.09
Price to sales (P/S)
15.8
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
15.93
Earnings
Revenue
$410.22M
EBIT
-$40.77M
EBITDA
-$33.61M
Free cash flow
$9.41M
Per share
EPS
-$0.7
Free cash flow per share
$0.16
Book value per share
$4.45
Revenue per share
$6.79
TBVPS
$10.2
Balance sheet
Total assets
$616.24M
Total liabilities
$348.54M
Debt
$222.28M
Equity
$267.7M
Working capital
$425.37M
Liquidity
Debt to equity
0.83
Current ratio
4.72
Quick ratio
4.12
Net debt/EBITDA
0.01
Margins
EBITDA margin
-8.2%
Gross margin
52.6%
Net margin
-10.3%
Operating margin
-7.2%
Efficiency
Return on assets
-10.7%
Return on equity
-20.2%
Return on invested capital
-15.4%
Return on capital employed
-8.1%
Return on sales
-9.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TNDM stock price

How has the Tandem Diabetes Care stock price performed over time

Financial performance

How have Tandem Diabetes Care's revenue and profit performed over time
Revenue
$410.22M
Gross profit
$215.61M
Operating income
-$29.47M
Net income
-$42.22M
Gross margin
52.6%
Net margin
-10.3%
The net income has plunged by 154% from the previous quarter but it has increased by 23% YoY
The net margin has plunged by 145% from the previous quarter but it has increased by 47% YoY
The operating income has shrunk by 53% QoQ and by 5% YoY
Tandem Diabetes Care's gross profit has increased by 47% YoY and by 2.1% from the previous quarter

Growth

What is Tandem Diabetes Care's growth rate over time

Valuation

What is Tandem Diabetes Care stock price valuation
P/E
N/A
P/B
24.09
P/S
15.8
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
15.93
Tandem Diabetes Care's EPS has plunged by 150% from the previous quarter but it has increased by 11% YoY
The company's equity has surged by 84% YoY and by 29% QoQ
TNDM's price to book (P/B) is 21% more than its last 4 quarters average of 19.9
The P/S is 143% higher than the 5-year quarterly average of 6.5 and 42% higher than the last 4 quarters average of 11.1
TNDM's revenue is up by 46% year-on-year and by 4.1% since the previous quarter

Efficiency

How efficient is Tandem Diabetes Care business performance
Tandem Diabetes Care's ROS has plunged by 142% from the previous quarter but it has increased by 48% YoY
TNDM's ROE has plunged by 117% from the previous quarter but it has soared by 53% YoY
The return on assets has dropped by 95% since the previous quarter but it has surged by 58% year-on-year
The return on invested capital has dropped by 69% since the previous quarter but it has surged by 68% year-on-year

Dividends

What is TNDM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TNDM.

Financial health

How did Tandem Diabetes Care financials performed over time
The total assets is 77% greater than the total liabilities
The total assets has surged by 142% year-on-year and by 80% since the previous quarter
Tandem Diabetes Care's quick ratio has soared by 93% YoY and by 92% from the previous quarter
The debt is 17% less than the equity
The company's equity has surged by 84% YoY and by 29% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.